The Breast Cancer Research Foundation
October 16, 2009
Dr. Hudis in the Chief of Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center in New York City. His research focuses on the role played by a universal enzyzme, COX-2, in breast cancer, with the belief that COX-2 is more activated in some kinds of breast cancer and that its inhibition will help to better prevent and treat the disease. For more information about Dr. Hudis, click here.